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Abstract: Research on iron oxide-based magnetic nanoparticles and their clinical use has been, so
far, mainly focused on the spherical shape. However, efforts have been made to develop synthetic
routes that produce different anisotropic shapes not only in magnetite nanoparticles, but also in other
ferrites, as their magnetic behavior and biological activity can be improved by controlling the shape.
Ferrite nanoparticles show several properties that arise from finite-size and surface effects, like high
magnetization and superparamagnetism, which make them interesting for use in nanomedicine.
Herein, we show recent developments on the synthesis of anisotropic ferrite nanoparticles and
the importance of shape-dependent properties for biomedical applications, such as magnetic drug
delivery, magnetic hyperthermia and magnetic resonance imaging. A brief discussion on toxicity of
iron oxide nanoparticles is also included.
Keywords: anisotropy; magnetic nanoparticles; hyperthermia; magnetic resonance imaging;
drug delivery
1. Introduction
Many efforts are being made to overcome the flaws of cancer treatment and diagnosis.
Nanomedicine is the field of nanotechnology responsible for the development of biomedical tools
capable of a higher performance than conventional medicine [1,2]. Ferrite nanoparticles are magnetic
nanoparticles that show several properties that result from finite-size and surface effects such as
high magnetization, superparamagnetism and extra anisotropy contributions. The fact that these
nanoparticles do not retain any magnetization upon removal of an applied magnetic field, along with
the low toxicity, biocompatibility and strong magnetic properties, endow iron-based nanoparticles as
suitable materials for use in bioimaging, cancer theranostics and drug delivery [3]. The dependence
between magnetic behavior and size results from the structure of their magnetic domains. When size
decreases to a threshold value (commonly 20 nm [4]), the ferrimagnetic material becomes a single
domain which is characterized by a uniform magnetization [5,6]. Spinel ferrite nanoparticles have
ferrimagnetic behavior, and this means that the material is composed of magnetic domains, each one
composed of antiparallel magnetic moments with different magnitudes, resulting in a net spontaneous
magnetic moment. When a magnetic field is applied, all domains have their magnetic moments aligned
with the magnetic field, resulting in a large net magnetic moment [5–8].
Ferrite nanoparticles are composed of different atoms occupying two different lattice sites.
Magnetite (Fe3O4) is a ferrite, but other ferrites can be formed when a Fe2+ ion is replaced by another
cation (Mn2+, Zn2+, Co2+, Mg2+, Ni2+) [7,8]. The general structure of a normal spinel structure can be
written as (Me2+)[Fe3+2]O4, where Me+2 refers to divalent cations, occupying tetrahedral positions,
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and Fe3+ serving as trivalent cations, occupying octahedral positions [7,8]. Given their unique structural
and magnetic properties, ferrite nanoparticles have been widely used for magnetic drug delivery [9–11],
magnetic hyperthermia [12–14] and magnetic resonance imaging [15–17]. Research on preparation
methods and characterization of different anisotropic shapes of these nanoparticles is important and it
is recently increasing, since desired physicochemical properties and applications can be achieved by
simply change structural parameters [18–22]. The magnetic behavior of ferrite nanoparticles is highly
influenced by shape anisotropy. For instance, magnetization of an elongated nanoparticles will be
easier along their long axis than the short axis [23].
In this review, we aim to explore the recently developed synthetic routes of preparation of different
anisotropic nanoparticles, namely elongated nanoparticles, nanofilms, sheets and plates, nanocubes and
nanoflowers. Herein, we highlight the importance of utilization of anisotropic iron oxide nanoparticles
as alternative materials for an enhanced performance in biomedical applications, such as magnetic
drug delivery, magnetic hyperthermia and magnetic resonance imaging (MRI). Also, the influence of
size, shape and administered dose on the toxicity of iron oxide nanoparticles is briefly discussed.
2. Synthesis of Shape Anisotropic Nanoparticles
Synthesis of nanoparticles with controlled shape has been a main challenge in the last decade [24],
yet most of the described methods and strategies are confined to magnetite nanoparticles. A gap is thus
kept between the shapes that have been already developed and the metal composition that would be of
interest to afford improved magnetic and contrast properties, besides other technological applications.
High-quality nanoparticles are attained by different methods, which can be separated in three main
classes: physical, chemical and biological [25]. Physical methods include pulsed laser ablation and
pyrolysis, while chemical encompass a wide variety of methods, such as co precipitation, hydrothermal
and solvothermal synthesis, thermal decomposition, sol-gel synthesis, sonochemical decomposition,
microemulsion, microwave-assisted and electrochemical synthesis [24–26]. Biological routes include
the bacterial and microorganism synthesis [24–26]. The advantages and disadvantages of the common
methods are included in Table 1, besides examples of spherical and anisotropic shape nanoparticles
obtained through each method.
Table 1. Common methods used in the synthesis of iron oxide nanoparticles, advantages and
disadvantages, and references. Examples of isotropic and anisotropic shape nanoparticles are included.
Method Advantages Disadvantages Ref. Examples
Laser Ablation
Synthesis in
Solution (LASiS)
Green synthesis
Different structures
and composition
Difficult control of
particle size and clustering [27,28] [29,30]
Chemical vapor
deposition
(laser and spray
pyrolysis)
Easy to prepare
Production of small particle
size
Expensive equipment
Gaseous interferences [26,31–33] [34–37]
Co-precipitation
Green
Low-cost
Scalable
Facile
Efficient
Difficult to control size
Polydispersity
Lack of precise stoichiometric
phase control
[26,28,31,32,38] [39–41]
Thermal
decomposition
Small size particles
Control of size and shape
Monodisperse
Requires multiple steps
Toxic solvents
Toxic and expensive precursors
Laborious purification
Requires surface treatment
after synthesis
[31,33] [42,43]
Hydrothermal
(solvothermal)
Green
Versatile
Control of morphology
Need of autoclave
Control of dispersity
Slow reaction kinetics
[28,33] [44,45]
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Table 1. Cont.
Method Advantages Disadvantages Ref. Examples
Sol-gel synthesis
Homogeneous
Control of shape and length
Low-cost
High phase purity
Requires post treatment
By-products
Safety
Low efficiency
[28,33] [46,47]
Sonochemical
decomposition
Mild experimental conditions
Good crystallinity
Versatile
Mechanism not still understood [26,32,43] [48,49]
Microemulsion
Monodispersity
Simple equipment
High control of size and shape
Room conditions
Small sizes
Removal of surfactants
High solvent consumption
Low-yield
Difficult scale-up
[26,28,31,33] [50]
Electrochemical
synthesis
Control of particle size
Simple and fast Lack of reproducibility [32] [51,52]
Biosynthesis
High yield
Reproducibility
Scalability
Low cost
Room temperature
Time-consuming
Laborious [31,32] [53,54]
The crystal shape can be thermodynamically or kinetically controlled. A thermodynamic
process is associated with the chemical potential of the reaction, that is related to parameters such
as temperature and supersaturation of the solution, while a kinetic process happens when stable
nucleation sites in supersaturated regions are present, which reduce the reaction energy barrier [55].
During the thermodynamically-driven growth, the reaction proceeds to reduce the particles surface free
energy [23,55]. Here, the two mechanisms, reaction-limited and diffusion-limited, affect differently the
rate of deposition of atoms in the nuclei surface. At high solution concentration, in the diffusion-limited
regime, monomers are precipitated once on the surface of the NPs, which favours monodisperse
nanoparticles, while at low concentration, in the reaction-limited regime, the surface reaction limits
the growth and leads to different final shapes [23]. Therefore, parameters such as temperature, pH,
solvent and concentration of the precursors affect the final shape [55,56]. Considering the relative
surface energies of the crystal facets, different strategies have been studied to favour anisotropic shapes,
including the use of shaping ligands, template-assisted synthesis and electrodeposition, and magnetic
assembly of nanoparticles [23].
The use of shaping ligands is a common method to obtain anisotropic nanoparticles, which can
be induced through: (I) steric inhibition of growth and modification of chemical reactivity of specific
crystal planes by chelation of the ligand to specific planes; (II) coalescence of reactants or nuclei and
consequent anisotropic growth in templated ligand assembly. Common ligands include surfactants
such as oleylamine, dodecyldimethylammonium bromide, cetyltrimethylammonium bromide or
chloride, octadecylamine and oleic acid [23,55,56]. Common polymers include polyethyleneimine (PEI),
poly(ethylene glycol) (PEG), poly(vinylpyrrolidone) (PVP), poly(acrylic acid) (PAA) and poly(vinyl
alcohol) (PVA) [23,55,57]. Small molecules containing halides, small polymers and solvents are
also used for coordination of specific crystal planes [55,58]. Here, the functional groups have to
be considered as they affect the size, shape and magnetic properties of the crystals [23,58]. Li and
co-workers [58] demonstrated that the higher polarity of 3-aminopropanol compared to urea led to an
increased confinement effect of the magnetite nanocrystal growth through hydrothermal synthesis,
while urea was adequate to control nanoparticle shape owing for its surface plane preference σ{111} >
σ{001} > σ{101}. Another example of the capping agent effect was studied by Fatima and co-workers in
hydrothermal synthesis of magnetite [59], where cubes and octahedra of magnetite could be obtained
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using ferrous sulphate heptahydrate in ethylene glycol, and potassium hydroxide that was found to
favour a faster growth rate of {111} plane than the {100} plane.
Furthermore, pi-acceptor ligands (e.g. CO) are described to decrease saturation magnetization, Ms,
values, while the σ-donors (e.g. NH2) do not affect the magnetic properties [23]. Also, post-synthesis
surface-functionalization can affect phase distribution, as demonstrated by Daniel and co-workers [60].
The replacement of oleic acid by catechol surface ligands led to the separation into two distinctive
magnetic entities, due to reduction of a nanoparticle surface fraction to magnetite, which reduced the
anisotropy constant and, consequently, the effective magnetization [60].
2.1. Elongated Nanoparticles
Elongated magnetic nanoparticles, mainly nanorods, have been of interest in various
industrial [61,62], and biomedical applications [63–65]. Classification is based on the external energy
required for inversion of the magnetization [61]. Nanorods encompass structures with some nanometers
of diameter and length up to 100 nm, while the length of nanowires is larger, and nanotubes are hollow
nanorods [23]. The magnetic easy axis and magnetization directed along the long axis, which are
determined by the shape anisotropy, lead to an anisotropic response to an external magnetic field:
a S-like hysteresis loop is obtained when a magnetic field is applied parallel to the short axis, while
along the long axis the hysteresis loop is square-like [23]. The reader is directed to articles [66–69] for
more information on the magnetic behavior of elongated nanoparticles. Different strategies have been
developed in recent years for the synthesis of elongated iron oxide nanoparticles of different chemical
composition, which are summarized in Table 2.
Table 2. Common methods used in the synthesis of elongated iron oxide-based nanoparticles. The size
and saturation magnetization, Ms, values are also included.
Shape Structure Method Size(d × l, nm)
Ms
(emu/g) Ref.
Nanorods
Fe3O4
Hydrothermal + shaping ligand (EDA) 40–50 × 500–800 72.94 [70]
25 × 200 71.3 [71]
Co-precipitation + shaping ligand
(PVP) 18.2 × 310.6 28 [72]
Hydrothermal + sacrificial template
(goethite) ~70 × ~500 90 [73]
Solvothermal + template-assisted
(Fe3O4 microspheres)
7–20 × 120–400 92.3 [74]
MnFe2O4
Hydrothermal + sacrificial template
(MnO) 25–40 × 300–400 72.45 [75]
CoFe2O4
Hydrothermal 19 × 400 73.36 [76]
Solvothermal (EG) 100–200 l 54.93 [77]
Hydrothermal + shaping ligand (CTAB) 25 × 120 66 [78]
Co0.5Ni0.5Fe2O4 Microemulsion 30–200 l 51.1 [79]
CuFe2O4 Co-precipitation 120–400 l - [80]
Nanowires
Fe3O4 Sol-gel + shaping ligand (EG and P123)
10 d; >500 aspect
ratio 34.5 [81]
MnFe2O4 Hydrothermal 100–300 d 45.9 [82]
CoFe2O4
Sol-gel + template-assisted 40 d - [83]
Template-assisted 8–10 d 51.81 [84]
Nanotubes
Fe3O4 Template-assisted
30 d; 7 nm wall
thickness - [85]
CoFe2O4
Co-precipitation + Template-assisted 217 d 65 [86]
Sol-gel + template-assisted 50 d × 1000 l;5 nm wall thickness - [87]
Nanorods have been commonly obtained through hydrothermal reactions, which provides an
economical and convenient route for the synthesis of crystals with compositional and morphological
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control, without requiring extremely high temperatures and sophisticated processing [75,78]. On the
other hand, nanowires and nanotubes synthesis is commonly accomplished through template-assisted
strategies. Opposite to other strategies, a reproducible method for the synthesis of homogeneous
magnetite nanotubes (Figure 1A) was developed by Liu et al. [85], which consisted on the synthesis of
MgO nanowires grown on Si/SiO2 substrates, pulsed laser deposition of Fe3O4 onto the nanowires and
etching of the MgO inner cores with (NH4)2SO4. Yet, magnetic nanorods have been of higher interest
as theranostic agents. Through the hydrothermal method, Wan et al. [71], using ethylenediamine as
a shaping ligand, were able to synthesise uniform nanorods (Figure 1B), which were achieved later
in a greener synthesis strategy by Ding et al. [70] without use of benzene. A tuneable strategy for
the synthesis of magnetite nanorods (Figure 1C) has also been developed by Mohapatra et al. [88],
which consists on the synthesis of PEI coated FeOOH nanorods and its reduction with oleylamine.
The control of size between 25 nm and 70 nm is attained by varying PEI concentration, which adsorbs
on the plane {200} of the nanorods [89,90]. The nanorods are then reduced to magnetite by oleylamine
that acts as a reducing agent (electron donor) at 200 ◦C, besides acting as surfactant and solvent [88,91].
Figure 1. (A) TEM image of a Fe3O4 nanotube. Upper inset: Selected area electron diffraction of the
nanotube. Lower inset: HRTEM image taken on the tube wall. Reproduced from [85] with permission
from American Chemical Society, 2020. (B) SEM image of magnetite nanorods described in [71].
Reproduced from [71] with permission from Elsevier, 2020. (C) Scheme of the two-step synthesis of
magnetite nanorods. Adapted from [88] with permission from Royal Society of Chemistry, 2020.
Nanorods of CoFe2O4 are commonly obtained through a shaping ligand-assisted synthesis using
oleic acid or CTAB as a surfactant [77,78,92]. Cobalt ferrite nanoparticles have remarkable properties,
such as tuneable coercivity, large anisotropy and moderate saturation magnetization [77]. Yet, their
application in the biomedical field is restricted owing to cobalt toxicity. Other ferrites, such as MnFe2O4,
CaFe2O4 and MgFe2O4, have advantageous properties for biomedical applications; although, strategies
for the synthesis of nanorods of these materials are lacking.
2.2. Nano- Films, Sheets and Plates
Two dimensional materials consist of plate-like magnetic nanoparticles, which magnetization in
soft-magnetic materials lies parallel to the basal plane, requiring a strong magnetic field to align the
magnetization out of the plane [23].
Thin films of magnetite have been commonly obtained through deposition techniques such
as molecular beam epitaxy and pulsed-laser deposition [93]. Recently, Zukova et al. [93] were
able to grow magnetite films using pulsed injection metallorganic chemical vapour deposition (PI
MOCVD) on Al2O3 (0001) and MgO (001) substrates, which displayed a preferred (111) crystalline
orientation. The authors denoted that the magnetic properties could be tuned through application of a
1T magnetic field during the film growth and also upon cooling. Another strategy to obtain magnetic
nanofilms is the layer-by-layer method. For example, Grigoriev et al. [94,95] were able to synthesize
Int. J. Mol. Sci. 2020, 21, 2455 6 of 25
polyelectrolyte/magnetite nanoparticle multilayer films by the layer-by-layer self-assembly technique
and evaluated the dependence of the refractive index on the increase of layers.
Other bidimensional shapes, such as nanosheets or nanoplates, have attracted more attention
than nanofilms. Different strategies have already been used to obtain magnetite nanosheets, including
hydrothermal synthesis [96], or soft-template assisted synthesis [97], affording nanosheets with good
crystallinity and magnetic properties. A simple strategy was developed by Wang et al. [98], which
consists of microwave-assisted coprecipitation of ferrous sulphate in a mixture of ethylene glycol
and water, affording nanosheets with good crystallinity and saturation magnetization around 30
emu/g. Zhuang et al. [99] were able to synthesize magnetite nanosheets through a solvothermal
method using diethylene glycol, which, through the inhibition of the crystal plane (111), favours
the formation of magnetite sheet-like crystals. Furthermore, the authors demonstrated that the
nanoparticles self-assemble into chain-like structures along the direction of the external magnetic field,
known as photonic crystals, which display a magnetochromatic property. A scale-up of the synthesis of
good quality and homogeneous nanosheets (Figure 2) has been developed by Chin et al. [100], which
consisted in the immersion of Fe substrates into a 70 ◦C solution of HCl and KCl under an O2 rich
environment. Strategies have also been developed for the synthesis of nanosheets based on other
ferrites, mainly CoFe2O4 through template assisted [101–103], and thermal decomposition [104].
Figure 2. SEM image at different magnifications of magnetite nanosheets. Adapted from [100] with
permission from American Chemical Society, 2020.
Magnetite nanoplates synthesis have also been reported through a hydrothermal route [105,106],
with a saturation magnetization above 60 emu/g. An alternative to hydrothermal route has been
proposed by Chen et al. [107], through the use of coprecipitation assisted with ultrasound irradiation,
which does not require protection from oxygen and high temperatures, producing nanoplates with
thickness ranging from 10 nm to 20 nm and lateral size between 50 nm and 90 nm. Hexagonal nanoplates
have been obtained by Zhut et al. [108] through a hydrothermal synthesis using β-cyclodextrin and
urea as, respectively, reducing agent and growth modifier. The nanoplates exhibit an average diameter
of 400 nm and thickness of 40–80 nm, attaining a saturation magnetization close to 80 emu/g. Ma et
al. [109] also synthesized hexagonal nanoplates with maximum magnetization above 70 emu/g through
the Schikorr reaction in a hydrothermal route (Figure 3A), which is the formation of iron oxide and
molecular hydrogen through oxidation of iron(II) hydroxide under anaerobic conditions. Recently, Xu
et al. [110] were able to synthesize ultra-thin triangular magnetite nanoplates through a seed-mediated
synthesis, where the seeds were obtained through the thermal decomposition of ferric oleate complex
at 310 ◦C, and a growth-step (replenished with monomers) was carried out at a temperature (240 ◦C)
lower than the required for nucleation (310 ◦C), but higher than the thermal decomposition of the
complex (230 ◦C).
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Figure 3. (A) SEM images of hexagonal-shaped magnetite nanoplates at different magnifications.
Reproduced from [109] published in Open Access by Springer. (B) TEM images of triangle-shaped
magnetite ultra-thin nanoplates at different magnifications. Adapted from [110] with permission from
Royal Society of Chemistry, 2020.
Recently, the synthesis of Co1-xCuxFe2O4 has been achieved through a two-step synthesis, starting
with coprecipitation of the metal salts in the right ratio, which dried powder was subjected to thermal
decomposition in air at 400 ◦C in a tubular furnace [111]. MnxFe1-xO nanoplates has also been recently
reported, which are of biomedical interest owing to the resistance to oxidation in air compared to
MnO and FeO, making them good candidates for magnetic contrast agents [112]. The synthesis was
achieved through thermal decomposition of acetonate precursors under N2 atmosphere, affording
nanoparticles that reach a saturation magnetization of 30 emu/g. The synthesis of Ni1-xMnxFe2O4 thin
cubic nanoplates has also been obtained through coprecipitation of the metal salts in the right ratio
and assisted with oleic acid as surfactant, to avert agglomeration during the reaction [113,114].
2.3. Nanocubes and Flowers
Despite the already described advances in the synthesis of colloidal iron oxide magnetic materials,
efforts are still ongoing to attain facile and sustainable synthetic protocols for controlling the shape
of nanoparticles. A protocol that allows control of nanoparticles was developed by Sayed and
co-worker [115], in which through a microwave assisted method and by changing only the iron
precursor, different shapes could be obtained such as distorted cubes, nanocubes and flowers (Figure 4).
Figure 4. (A) SEM image of distorted cubes. (B) TEM image of nanocubes. (C) SEM image of
self-oriented flowers. Reproduced from [115] with permission from Springer Nature, 2020.
A thermal decomposition method to synthesize magnetite flowers was developed by Guo et
al. [116] using FeCl3.6H2O, urea and tetrabutylammonium bromide dissolved in ethylene glycol,
which afforded particles with an average diameter of 1–3 µm and a saturation magnetization up to
80 emu/g. Later, Wang et al. [117] followed the reaction mechanism through electron microscopy,
which proceeds as nucleation, aggregation and Ostwald ripening, and finally the oriented growth
was also accompanied by Ostwald ripening. Flower-like particles have also been obtained through
solvothermal routes. Li et al. [118] synthesized flower microspheres through solvothermal reaction
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with urea in ethylene glycol (200 ◦C, 4 h), which afforded particles that reach a magnetization in
saturation up to 80 emu/g. A different particle architecture was developed by Wang et al. [119]
through the solvothermal route, using CTAB and sodium acetate in ethylene glycol (200 ◦C, 24 h), that
afforded hollow microspheres with a Ms of 80 emu/g. Other flower-like architecture is exhibited by the
multicore particles, in which the interaction between the cores leads to a large magnetic moment and
weak remanence magnetization [120]. Gavilán et al. [120] developed different methods to synthesize
multi-core nanoparticles through the use of polyols as reducing agents, obtaining nanoflowers as small
as 50 nm and Ms value of 100 emu/g. Through the use of succinic acid, urea and FeCl3.6H2O in a
solvothermal route, Cheng et al. [121] were also able to synthesize flower-like multi-core nanoparticles
with ca. 300 nm, while the use of 1,2-propylene glycol as solvent afforded nanoparticle clusters with ca.
50 nm. Recently, Shubitidze et al. [122] reported a coprecipitation method using dextran and NaNO3
that afforded nanoflowers with sizes of 20 nm to 40 nm.
Anisotropic nanoparticles have been sought as a solution to improve T2 contrasting properties as
the relaxivity can be enhanced by increasing the effective radius of the magnetic core, which is majorly
morphologic dependent [123]. For example, Zhao et al. [100] synthesized octapods (Figure 5A) through
thermal decomposition of iron oleate in the presence of NaCl. This strategy afforded nanoparticles
with an average length of 30 nm, which displayed an ultrahigh transverse relaxivity value of 679.3 30
mM−1 s−1. Common methods for the synthesis of nanocubes include thermal decomposition of iron(II)
oleate or iron(III) acetylacetonate complexes [124,125]. Recently, Muro-Cruces et al. [126] synthesized
cubic MFe2O4 (M = Fe, Co, Mn) (Figure 5A,B) and Mn3O4 through the thermal decomposition of the
right ratio of metal acetylacetonates in the presence of sodium oleate and oleic acid, in a mixture of
1-octadecene, dibenzyl ether and 1-tetradecene. Through this pathway, the authors were able to control
the size variation in 1–2 nm and obtain monodisperse nanoparticles with high crystallinity, which is
a critical control requirement to develop new materials for decreasing nuclear magnetic resonance
relaxation time T2.
Figure 5. TEM image of (A) CoFe2O4 and (B) MnFe2O4 nanocubes. Adapted from [126] with permission
from American Chemical Society 2020.
3. Biomedical Applications of Anisotropic Iron Oxide Nanoparticles
The use of iron oxide nanoparticles (IONs) in cancer therapy and diagnosis (theranostics) has been
of major interest regarding their unique physicochemical properties, namely, their superparamagnetic
behavior, high magnetization and chemical stability [127–129]. The already reported influence of shape
in the physicochemical properties and magnetic behavior of IONs [130–133] was a starting point to
further research on the impact of shape anisotropy in biological behavior and imaging properties. Next
sections are focused on recent developments in magnetic drug delivery, magnetic hyperthermia and
magnetic resonance imaging (MRI).
3.1. Magnetic Drug Delivery
IONs can accumulate in tumor sites by passive or active targeting. Passive targeting occurs when
nanoparticles can extravasate from the bloodstream and enter in tumor cells through the enhanced
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permeability and retention (EPR) effect [134,135]. On the other hand, active targeting with an applied
magnetic field takes advantage on the responsiveness of magnetic nanoparticles towards a magnetic
field [136,137]. IONs can also be coated with synthetic and natural polymers [130,138,139], surfactants
and fatty acids [31,140] and functionalized with targeting ligands [130,141], which allows the use of
these nanoparticles as drug delivery systems with improved selectivity and pharmacokinetics [142,143].
The superparamagnetic properties demand that nanoparticles have small sizes, preferably below
~20 nm [4]. However, at this size, magnetic moments of nanoparticles are small, so magnetic response can
be compromised. Self-assembly of individual nanoparticles into nanoclusters is one possible strategy to
overcome this problem. Kralj et al. [144] developed nanochains and nanobundles from nanoclusters of
maghemite (γ-Fe2O3) with preserved superparamagnetism, zero coercivity and good colloidal stability.
Other elongated structures, like nanotubes or nanorods, are also being investigated for drug delivery.
Iron oxide nanorods have attracted attention due to their superparamagnetic behavior [145] and
capacity of intracellular delivery with controlled-release profile and biocompatibility [146]. Nanotubes
have the advantage of enabling the loading of large amounts of bioactive compounds in their inner
voids, while the outer surface can be coated or functionalized with targeting ligands (Figure 6A,B) [147].
Figure 6. TEM images of 200 nm (A) and 60 nm (B) nanotubes with magnetite. Scale bars, 200 nm.
Adapted from [147] with permission from Elsevier, 2020.
Magnetic nanotubes combine the magnetic and tubular properties allowing a differential
functionalization of the inner and outer surfaces, which shows the potential of these nanostructures for
magnetically assisted drug delivery and bioimaging [148]. A study regarding the use of iron oxide
nanotubes as carriers for insoluble anticancer drugs showed that hematite nanorods were in a higher
extent and more quickly internalized than nanospheres in human carcinoma cells [149]. After achieving
this conclusion, the researchers developed PEGylated maghemite nanorods loaded with paclitaxel
(PTX-PMNTs) and demonstrated that these nanocarriers have important properties for a successful
magnetic drug delivery such as higher drug loading capacity, increased carcinoma uptake in the
presence of a magnetic field and a pH-activated release profile. In 2014, Yu et al. [150] synthesized iron
oxide porous nanorods functionalized with folic acid for targeted delivery of another low water-soluble
anticancer drug, doxorubicin. In this study, the researchers demonstrated that the presence of folic
acid on the surface of nanorods increased cellular uptake of nanorods and cytotoxicity of doxorubicin
in HeLa cells, because of the specific binding between folic acid and folate receptors, thus showing the
potential of these nanocarriers for targeted drug delivery in tumor cells. More recently, an innovative
nanosystem was developed by Kwak et al. [65], being composed of Au blocks (plasmonically-active
domain) and Ni blocks (magnetically-active domain), with a silica-coated surface for drug loading
(Figure 7A,B).
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Figure 7. FE-SEM images of Au/Ni/Au nanorods (A) and silica-coated Au/Ni/Au nanorods (B) and
respective schematic representations. Adapted from [65] with permission from Royal Society of
Chemistry, 2020.
A rotating magnetic field will induce fluctuations of magnetic-responsive parts and consequently
produce periodic fluctuations in optical measurements that can be converted by Fourier transform
in a dominant frequency peak. The release rate of loaded drug can be controlled by changing the
speed of the applied magnetic field, which in turn, is monitored by frequency peak shifting. In this
study, doxorubicin was loaded in these nanorods and its release rate was higher when the speed of
the rotating magnetic field increased, confirming the controlled release using magnetic modulation.
Besides that, a linear decrease in cell viability was shown in HeLa cells as a function of magnetic field
speed and release time. In 2013, Xiong et al. [151] produced Rubik-like magnetic nanoassemblies
(MNAs) composed of four oleic acid-capped iron oxide nanocubes (Fe3O4@OA NCs) with a shell of
dioleate-modified polyethylene glycol (OA2-PEG) (Figure 8A,B). Here, the researchers investigated the
antitumor effect of paclitaxel-loaded MNAs in vitro using B16F10 culture cells and in vivo in B16F10
melanoma-bearing mice and demonstrated higher antitumor activity of these nanosystems, compared
with the same amount of free paclitaxel (also known as taxol), as well as an enhanced intracellular
delivery in the presence of a magnetic field. The pharmacokinetics study allowed concluding that the
incorporation of paclitaxel in MNAs increased the amount and retention time of the drug in plasma,
also an important parameter to be considered in drug delivery.
Figure 8. TEM image (A) and schematic representation (B) of Rubik-like paclitaxel-loaded magnetic
nanoassemblies. Adapted from [151] with permission from Elsevier, 2020.
3.2. Magnetic Hyperthermia Therapy
Cancer cells can be killed when exposed to high temperatures between 41 and 47 ◦C in a process
known as hyperthermia [152]. Magnetic hyperthermia can be induced when magnetic nanoparticles
are exposed to an alternating magnetic field (AMF) and produce heat due to Néel and Brownian
relaxations of the rotating magnetic moments [152,153]. Metallic nanoparticles (Fe, Ag, Ni, Gd, TiO2)
have the highest saturation magnetization, but their inherent toxicity and chemical instability make
them not suitable for biomedical applications. Thus, the most used nanoparticles for hyperthermia
applications are iron oxide nanoparticles that show low toxicity, facile fabrication and advantageous
physicochemical properties [153,154]. This treatment can be combined with specific delivery of
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therapeutic drugs into the tumor cells, in order to increase the therapeutic effect and reduce the needed
dosage and side effects [152–154].
The heating power of magnetic nanoparticles strongly depends on extrinsic and intrinsic properties,
namely the external magnetic field amplitude, the saturation magnetization and the anisotropy energy,
which in turn, depends on shape of nanoparticles, so a suitable design of these nanoparticles is an
important step for enhanced hyperthermia efficiency [155]. The increase of heating efficiency allows the
use of a lower dose of nanoparticles, preventing this way undesirable accumulation and cytotoxicity.
Nanocubes have been extensively studied for hyperthermia applications. Guardia et al. [156]
reported significant SAR values of nanocubes with 19 nm of edge length, at frequencies and magnetic
field amplitudes considered safe for clinical use (a SAR value of 875 W/g at 320 kHz and 10 kA.m−1),
as well as high hyperthermia efficiency, promoting 50% of cancer cell mortality in a temperature range
of 40 to 45 ◦C, at 110 kHz and 20 kA.m−1. Thermo-sensitive coated nanocubes have the ability of
combining hyperthermia with chemotherapy by creating a synergistic therapeutic effect through heat
triggered drug release, while maintaining their good magnetic properties and high SAR values [157].
The coating of magnetic nanoclusters seems to be a suitable strategy to create colloidally-stable
solutions of nanoparticles aggregates taking advantage of magnetic and heating properties of different
geometries. Niculaes et al. [158] prepared and compared oleic acid-coated iron oxide nanocubes with
different geometries – single nanocubes, dimer and trimer assemblies, and centrosymmetric structures
(with more than 4 nanocubes) – in terms of their magnetic properties and SAR values (Figure 9A–C).
The SAR value of dimer and trimer structures was higher (253 W/g) than the one obtained for individual
nanocubes (213 W/g) and a significantly decrease was observed for centrosymmetric assemblies (184
W/g). Dimer and trimer nanoclusters also had the highest saturation magnetization (MS) values.
However, it was demonstrated that not Ms but magnetic dipolar effect is the major factor for the
enhancement of SAR values (and not the MS values).
Figure 9. TEM images of dimer and trimer (A) and centrosymmetric (with more than 4 nanocubes)
(B) iron oxide nanoclusters; (C) SAR values of the different nanoassemblies shows that dimer and
trimer structures have the highest SAR values. Adapted from [158] with permission from American
Chemical Society 2020.
Geng et al. [159] demonstrated that iron oxide nanorods show enhanced specific absorption
rates (SAR) (1072 W/g at 33 kA.m−1) comparing with their spherical counterparts (262 W/g). Other
comparative study regarding the magnetic properties and heating efficiency of magnetite nanorods and
spherical nanoparticles allowed demonstrating that the samples of nanorods possess higher Ms values
than the ones with spherical nanoparticles of the same volume [160]. Then, AC (alternating current)
hyperthermia experiments showed that the increase of the aspect ratio (for a limited concentration of
nanoparticles, 3 mg/mL) and alignment of nanorods in the direction of the AC field are key factors for
an enhanced heating efficiency. Additionally, the researchers obtained higher SAR values for magnetite
nanorods (862 W/g at 800 Oe) when compared to nanocubes and nanospheres (314 W/g and 140 W/g,
respectively).
Not only nanorods and nanocubes are promising enhancers of heating efficiency. Magnetite
nanodiscs were also investigated and, again, higher SAR values (2 times higher) for nanodiscs were
obtained in comparison with their spherical counterparts [161]. More important, it was demonstrated
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that the high SAR value for nanodiscs in an aqueous solution (4.66 kW/g) is due to their parallel
orientation to the applied AC field and can be maintained in a range of orientations of 60◦ to 90◦.
Ag/Fe3O4 core-shell nanoflowers were used in combined magnetic hyperthermia and photothermal
therapy, taking advantage of both plasmonic and magnetic properties and allowing an increase of more
than one order of magnitude of SAR values when a laser is simultaneously applied (Figure 10A–C) [162].
Figure 10. (A) TEM image of Ag/Fe3O4 nanoflowers; (B) Temperature reached after 300 s of heating for
different ac field intensities. The therapeutic temperature window (blue zone) is reached for lower
magnetic field intensities when a laser is applied; (C) SAR values of Ag/Fe3O4 nanoflowers as a function
of AC field intensity (HAC) for different laser power densities. SAR values are the highest when a laser
is simultaneously applied. Adapted from [162] with permission from American Chemical Society, 2020.
As mentioned before, nanotubes have high MS and increased surface area that allows higher drug
content due to their hollow morphology. The possibility of enhancing the therapeutic efficiency of a
drug is now of major importance, justifying the development of multifunctional nanoparticles capable
of a synergistic effect between efficient heating and drug delivery. Following this, Das et al. [163]
prepared highly crystalline Fe3O4 nanotubes and measured the SAR values, in water and in 2% agar,
for randomly dispersed and magnetically aligned nanotubes. A SAR value of 360 W/g for an AC
magnetic field of 800 Oe was obtained for randomly dispersed nanotubes in water. For applied fields
of 600 and 800 Oe, nanotubes aligned to the magnetic field had improvements in SAR of 65% and
80%, respectively, comparing to randomly dispersed nanotubes. This, again, confirms the importance
of the alignment of anisotropic nanoparticles to the applied magnetic field in order to enhance the
heating efficiency.
3.3. Magnetic Resonance Imaging (MRI)
Iron oxide nanoparticles have been extensively exploited as enhanced contrast agents in magnetic
resonance imaging (MRI). The main advantages of MRI are high spatial resolution, soft tissue contrast
and, most important, the possibility to early detect the presence of tumors, increasing therapy
success [164]. Thus, the conception of new strategies that can optimize this technique is of major
relevance. Superparamagnetic iron oxide nanoparticles (SPIONs) are strong candidates to be used
as contrast agents due to their biocompatibility and ability to increase contrast enhancement [165].
A contrast in MRI image depends on nuclear relaxation times of the tissue protons, which can be
longitudinal (T1) or transversal (T2) [166–168]. Positive contrast agents (T1) decrease longitudinal
relaxation time, resulting in a brighter image, while negative contrast agents (T2) decrease transversal
longitudinal relaxation time, causing a darkening in MRI image [166–168]. The behavior of a contrast
agent essentially depends on longitudinal and transversal relaxivity, r1 and r2, respectively, indicating
if it is more susceptible to be positive (T1) or negative (T2) [166–168]. Commonly, SPIONs are used for
darkening T2-weighted images, but it was already reported that these nanoparticles are also capable
to provide positive contrast enhancement, overpassing the toxicity of the usual gadolinium chelates
contrast agents [169–171].
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The beforementioned studies regarding the use of iron oxide nanoparticles in drug delivery and
hyperthermia treatment evidenced that anisotropy of nanoparticles is a key factor for improving its
properties. This way, researchers started to investigate the morphology dependence of nanoparticles
in the enhancement of magnetic relaxivity in MRI [172,173]. Lee et al. [174] demonstrated that 22
nm-sized nanocubes have a higher r2 value (761 s−1 mM−1) compared with nanocubes with larger sizes
and clear attenuation of the MRI signal in vivo, which opens the possibility of using nanoparticles
with smaller sizes and high colloidal stability as T2 contrast agents. Sharma et al. [124] synthesized
even smaller magnetite nanocubes (9.7 nm) with potential of simultaneous contrast enhancement
of T1 and T2-weighted MRI, acting as dual contrast agents (Figure 11A,B). Later on, Cho et al. [175]
prepared BSA-coated assembled iron oxide nanocubes with high r2 relaxivity (~500 s−1 mM−1). These
nanoparticles, with an average size of 100 nm, were injected into mice bearing U87-MG tumor cells and
a clear darkening of tumor mass was detected, confirming their accumulation (Figure 11C). Moreover,
the tumor growth was successfully reduced with magnetic hyperthermia, which demonstrates the
potential of these nanoparticles in combined diagnostics and therapy. Zhao et al. [123] synthesized
iron oxide octapods with an edge length of 30 nm that exhibited a stronger contrast enhancement of
T2-weighted images and a much higher r2 value (679 s−1 mM−1) than spherical iron oxide nanoparticles
with similar geometric volume. Furthermore, these nanoparticles produced higher contrast in
T2-weighted MR imaging of a hepatic carcinoma than the spherical ones, indicating that iron oxide
octapods are efficient as T2 contrast agents. These results demonstrate that anisotropic shapes promote
the increase of the effective radii of nanoparticles enhancing their performance in T2-weighted MRI.
While the r2 values are influenced by not only the effective radii but also the saturation magnetization,
r1 values depend mostly on metal exposure at the surface of nanoparticles that promotes proton
coordination and chemical exchange [176,177]. This was emphasized by Zhou et al. [178] with the
preparation of several anisotropic iron oxide nanostructures, namely Fe3O4{111} facet exposed plates,
truncated octahedrons and tetrahedrons, and Fe3O4{100} facet exposed cubes, concaves, multibranches
and assembled structures. In this study, the r1 and r2 values were obtained and compared for all
nanostructures and it was demonstrated that Fe3O4{111} exposed cubes, octahedrons, tetrahedrons and
Fe3O4{100} exposed cubes (with sizes of both 15 and 21 nm) have a greater T1 relaxation shortening
effect than spherical nanoparticles, because of the metal-rich surfaces. The concaves and multibranches
had lower r1 values similar to the one for spherical nanoparticles. The highest r1 and r2 values
were obtained for 21 nm sized cubes, possibly due to spin-canting effect, in the case of T1 relaxation,
and higher Ms and relatively large effective radii, in the case of T2 relaxation, when comparing with
the remaining nanoparticles.
Among the elongated nanoparticles, nanorods were mentioned before as efficient systems for
hyperthermia treatment because of their high MS values. Knowing that higher magnetization leads to
a shortening effect of T2 relaxation time, it can be expected that nanorods are good T2 contrast agents.
In fact, Mohapatra et al. [88] reported a high r2 value (608 s−1 mM−1) for magnetite nanorods of length
70 nm coated with polyethyleneimine (PEI). These nanorods were able to induce a stronger local
magnetic field over a larger volume comparing with spherical nanoparticles with equivalent volume,
due to their larger surface area, resulting in a faster dephasing of nearby protons and consequently a
higher r2 value is obtained. Later, the same group [179] prepared silica-coated magnetite nanorods
(Fe3O4@SiO2) with a length of ~520 nm and an r2 value of 192 s−1 mM−1. The nanorods promoted an
r2 darkening effect, exhibited high loading efficiency (65%) of doxorubicin and a pH-stimulated release
of the drug. These results indicate the potential of nanorods for combined therapy and diagnosis.
The treatment and imaging of colon cancer in mice was investigated by Dehvari et al. [180], who
developed pluronic-conjugated superparamagnetic nanorods loaded with paclitaxel. Here, tumor
growth was suppressed, and in vivo localization and visualization of the tumor was possible due to
the darkening effect promoted by the nanorods in T2-weighted MR images. More recently, elongated
magnetite nanoparticles were synthesized by an environmentally friendly hydrothermal method,
and it was demonstrated that the presence of larger pores resulted in the highest MS value (97 emu
Int. J. Mol. Sci. 2020, 21, 2455 14 of 25
g−1) and transversal relaxivity (r2 = 343 s−1 mM−1) [63]. It is worth to note that the abovementioned
iron oxide nanoparticles have higher transversal relaxivity values than the ones obtained for clinically
approved T2 contrast agents, such as Ferumoxide (Endorem® or Feridex®) and Ferrixan (Resovist®)
with r2 values of ~98 s−1 mM−1 [181] and ~150 s−1 mM−1 [182], respectively. More efficiency is now
being achieved in anisotropic nanoparticles for MRI applications and further research on their effects is
needed, namely in vitro and in vivo studies, in order to be clinically approved.
Figure 11. T1- (A) and T2-weighted (B) in vivo MR images before injection, immediately after and after
30 and 60 minutes of silica coated nanocubes. The contrast enhancement is clearly observed in the
coronal images of the kidney. Adapted from [124] with permission from Royal Society of Chemistry
2020. (C) T2-weighted in vivo MR images before (left) and 24 h after (right) injection of BSA-coated
nanocubes into mice bearing U87-MG tumor cells. The darkening of the tumor mass is clearly visible
after the injection of nanoparticles. Adapted from [175] with permission from MDPI 2020.
4. Cytotoxicity of Iron Oxide Nanoparticles
Besides the development of new strategies of synthesis and production of nanoparticles with
different structural characteristics, the interaction of nanoparticles with biological systems is an
important factor to be considered for long-term clinical use. The uptake and accumulation of iron oxide
nanoparticles in tumor cells will depend on their size, shape, surface charge and coating. It is desirable
that a great number of nanoparticles reaches the tumor environment without causing any harm to
healthy cells when circulating inside the body. This way, controlled size and shape of iron oxide
nanoparticles are fundamental parameters to be considered in their design for biomedical applications.
The range of sizes from 10 nm to 100 nm has been reported as the ideal. Nanoparticles with sizes
below 10 nm are easily cleared by kidneys, while nanoparticles with sizes larger than 100 nm are
phagocytized by macrophages and accumulate in the liver and spleen [183]. Cytotoxicity promoted by
iron oxide nanoparticles can result from different mechanisms, such as reactive oxygen species (ROS)
production, oxidative stress, membrane damage, genotoxicity and inflammatory responses [184,185].
ROS production is mainly due to the large surface area of iron oxide nanoparticles for generation of
free radicals and leaching of iron molecules from the surface by enzymatic degradation. This will lead
to oxidative stress and possibly causing cell death by apoptosis or necrosis. The most common way of
overcoming this problem and achieve colloidal stability is the surface coating of nanoparticles with
different polymers such as dextran, polyethylene glycol (PEG) and liposomes [186].
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However, some coatings can cause appreciable cytotoxicity. For example, Feng et al. [187]
demonstrated in vivo dose-dependent lethal toxicity of 10 nm poly(ethylenimine)-coated iron oxide
nanoparticles. Also, Ying et al. [188] concluded that, in a 24 h assay, iron oxide nanoparticles coated
with carboxyl groups have higher toxicity than those with amine groups in A3 human T lymphocytes.
Jarockyte et al. [189] prepared magnetite nanoparticles with a hydrodynamic size of about 50 nm and
studied the accumulation and toxicity of these nanoparticles in mouse embryonic fibroblasts. After 48
h, nanoparticles were mainly accumulated in the perinuclear region. Then, cell viability was tested for
3 h, 24 h and 48 h, with incubation of 32.5 ng/mL and 65 ng/mL of nanoparticles. After 3 h and 24 h, no
cytotoxicity was observed for both concentrations and, after 48 h, a dose-dependent decrease in cell
viability is observed.
Not only size but also the morphology of nanoparticles can influence cytotoxicity [190,191].
In vitro, shape will mostly influence the nanoparticle-cell membrane interaction, which in turn will
influence cellular uptake. Rod-shaped nanoparticles seem to have a more favorable cellular uptake
when compared with spherical nanoparticles, due to the larger area of contact between the cell and the
nanoparticle, so it is expectable that nanoparticles with this shape will accumulate in higher extent
in tumor cells. On the other hand, a higher accumulation of these nanoparticles can lead to cell
necrosis of non-tumorigenic cells, as demonstrated by Lee et al. [192]. In this study, rod-shaped iron
oxide nanoparticles were found to be more cytotoxic to mouse macrophage cells than the spherical
counterparts. On the other hand, Hu et al. [193] showed that iron oxide nanocubes produced low
cytotoxicity up to 0.5 mg Fe mL−1 in a mice monocyte macrophage cell line.
In vitro and in vivo studies show that cytotoxicity is size-, shape- and dose-dependent, but
these parameters differ according to the type of cell or tissue in which nanoparticles are being
investigated [194–197]. So, further investigation on iron oxide nanotoxicity in different types of tissues
is needed to achieve a more consistent knowledge on which range of sizes is the most suitable for a
certain organ and which concentration is safe to be applied.
5. Conclusions and Future Perspectives
Over the past years, many different strategies have been developed for the reproducible synthesis
of high-quality monodisperse anisotropic iron oxide-based magnetic nanoparticles, either through
physical, chemical or biological methods. Although most of the developed strategies are focused
solely in magnetite, methods for the synthesis of cobalt, manganese or nickel-doped ferrites have
started to be a target of research. Remarkably, the number of reported syntheses of anisotropic shape
nanoparticles has been continuously increasing, which is expected to improve further owing to the
progress of scientific theories ruling the shape control. Yet, scaling remains a problem to be addressed
and an evaluation of the therapeutic gains over the cost of production needs to be evaluated in future
works, so to facilitate shape anisotropic synthesis at industrial scale with the desired properties.
Considering the nanoparticles shapes discussed in this article, the synthesis of elongate-shaped
nanoparticles has been of major interest for drug delivery applications, owing to the superparamagnetic
behaviour, the control over drug-release profiles and biocompatibility. Furthermore, elongated
nanoparticles are able to induce a stronger local magnetic field over a larger volume than spherical
nanoparticles with equivalent volume, making them highly important as T2 contrast agents. Particularly,
nanotubes enable the possibility of differential functionalization of the inner and outer surfaces. Thus,
the inner voids can be optimized for the loading of bioactive compounds, while the surface might be
coated or functionalized with targeting ligands.
The high saturation magnetization of shape anisotropic nanoparticles allows the use of a lower
dose of nanoparticles, averting undesirable adverse and side effects. Particularly, nanorods and
nanocubes have shown promising hyperthermia results for cancer therapy. However, challenges still
remain at the chemical composition level, as magnetite is prone to the generation of reactive oxygen
species. Such can be overcome through investigation of other chemical compositions, such as ferrites
doped with calcium or magnesium, or surface passivation with an inert material.
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Hereby, future works should be focused on the facile fabrication of low toxicity anisotropic
nanoparticles with other ferrite chemical composition, so that the physicochemical properties can be
optimized and reduce the needed dosage of nanoparticles but also of the therapeutic drugs, and their
associated side effects. Also, the development of nanoparticles that combine a plasmonically-active
domain are of high interest, due to the possibility of taking advantage of both plasmonic and magnetic
properties, such as the attainment of higher SAR values when a laser is simultaneously applied without
requiring high magnetic hyperthermia conditions.
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